We are live on
!
Find out more
SGAM
Smith Group Asset Management Portfolio holdings
AUM
$2.46B
Turnover
25.53%
1-Year Est. Return
57.16%
This Fund
S&P 500
This Quarter
Est. Return
-3.55%
1 Year Est. Return
+57.16%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.63B
AUM Growth
-$332M
(-11%)
Cap. Flow
-$165M
Cap. Flow
% of AUM
-6.27%
Top 10 Holdings %
Top 10 Hldgs %
27.16%
Holding
459
New
61
Increased
86
Reduced
158
Closed
50
Avg Time Held
1.2
years
Top 10 Avg Time Held
1.1
years
Top 20 Avg Time Held
0.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$32.4M |
| 2 |
Foot Locker
FL
|
+$31.9M |
| 3 |
WP
Worldpay, Inc.
WP
|
+$30.7M |
| 4 |
Nike
NKE
|
+$24.8M |
| 5 |
Bank of New York Mellon
BNY
|
+$23.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DST
DST Systems Inc.
DST
|
+$64.8M |
| 2 |
Walt Disney
DIS
|
+$40.4M |
| 3 |
STRZA
Starz - Series A
STRZA
|
+$38.6M |
| 4 |
United Therapeutics
UTHR
|
+$24.4M |
| 5 |
SOLARWINDS INC COM STK (DE)
SWI
|
+$21.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.74% |
| 2 | Healthcare | 18.7% |
| 3 | Consumer Discretionary | 17.69% |
| 4 | Industrials | 12.49% |
| 5 | Consumer Staples | 10.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
XCRA
151
DELISTED
Xcerra Corporation
XCRA
| $1.89M | 0.07% |
301,280
-70
| -0% | -$448 |
2015 Q2
1 quarter
|
|
152
The Greenbrier Companies
GBX
$1.21B
| $1.87M | 0.07% |
58,167
-50
| -0.1% | -$2.1K |
2014 Q3
4 quarters
|
|
153
Interparfums
IPAR
$3.71B
| $1.72M | 0.07% |
69,450
-19
| -0% | -$539 |
2015 Q2
1 quarter
|
|
154
Tvardi Therapeutics
TVRD
$13.5M
| $1.63M | 0.06% |
3,170
-1
| -0% | -$669 |
2015 Q2
1 quarter
|
|
|
AFFX
155
DELISTED
Affymetrix Inc
AFFX
| $1.57M | 0.06% |
183,930
+1,640
| +0.9% | +$16.4K |
2014 Q2
5 quarters
|
|
156
DELISTED
Amicus Therapeutics
FOLD
| $1.48M | 0.06% |
105,780
-32,750
| -24% | -$514K |
2014 Q1
6 quarters
|
|
|
SYNH
157
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $1.45M | 0.05% |
36,151
+35,450
| +5,057% | +$1.55M |
2015 Q2
1 quarter
|
|
158
Citi Trends
CTRN
$406M
| $1.4M | 0.05% |
59,940
+55,761
| +1,334% | +$1.37M |
2014 Q2
5 quarters
|
|
159
Cytokinetics
CYTK
$8.61B
| $1.18M | 0.05% |
177,010
+170,570
| +2,649% | +$1.16M |
2013 Q3
8 quarters
|
|
160
DELISTED
Surmodics
SRDX
| $1.14M | 0.04% |
51,990
-10
| -0% | -$235 |
2014 Q4
3 quarters
|
|
161
Build-A-Bear
BBW
$307M
| $1.12M | 0.04% |
59,210
-101,900
| -63% | -$1.93M |
2014 Q4
3 quarters
|
|
|
ADMS
162
DELISTED
Adamas Pharmaceuticals
ADMS
| $1.1M | 0.04% |
65,640
-10
| -0% | -$228 |
2015 Q1
2 quarters
|
|
163
DELISTED
Trevena, Inc.
TRVN
| $1.07M | 0.04% |
+165
| New | +$815K |
2015 Q3
0 quarters
|
|
164
Exelixis
EXEL
$15.4B
| $1.05M | 0.04% |
+186,870
| New | +$1.02M |
2015 Q3
0 quarters
|
|
|
ACHN
165
DELISTED
Achillion Pharmaceuticals
ACHN
| $978K | 0.04% |
+141,510
| New | +$1.15M |
2015 Q3
0 quarters
|
|
|
DYAX
166
DELISTED
DYAX CORPORATION
DYAX
| $958K | 0.04% |
+50,180
| New | +$1.2M |
2015 Q3
0 quarters
|
|
167
Kyntra Bio
KYNB
$19.6M
| $928K | 0.04% |
+1,693
| New | +$1.03M |
2015 Q3
0 quarters
|
|
|
MNTA
168
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $904K | 0.03% |
+55,100
| New | +$1.13M |
2015 Q3
0 quarters
|
|
|
PGNX
169
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $893K | 0.03% |
+156,060
| New | +$1.2M |
2015 Q3
0 quarters
|
|
170
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $888K | 0.03% |
124,360
-33
| -0% | -$275 |
2015 Q2
1 quarter
|
|
|
TESO
171
DELISTED
Tesco Corp
TESO
| $881K | 0.03% |
123,340
-30
| -0% | -$259 |
2014 Q4
3 quarters
|
|
|
NTUS
172
DELISTED
Natus Medical Inc
NTUS
| $871K | 0.03% |
22,080
| – | – |
2014 Q4
3 quarters
|
|
173
Inovio Pharmaceuticals
INO
$102M
| $867K | 0.03% |
12,494
-3
| -0% | -$261 |
2014 Q2
5 quarters
|
|
174
BGC Group
BGC
$5.4B
| $830K | 0.03% |
156,993
-31
| -0% | -$180 |
2014 Q4
3 quarters
|
|
175
Opko Health
OPK
$1.14B
| $820K | 0.03% |
97,550
-20
| -0% | -$265 |
2015 Q1
2 quarters
|
|
Similar funds
MAMU
PC
RG
DIA
Smith Group Asset Management's Q3 2015 Portfolio in Review
As of Q3 2015, Smith Group Asset Management held 459 positions worth $2.63B, down 11% from $2.97B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Smith Group Asset Management withdrew a net $165M in Q3 2015, closing 50 positions and reducing 158 holdings. Its most notable exit was DST Systems Inc., an estimated $64.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Smith Group Asset Management opened a new position in Citrix Systems Inc worth $31.4M.
- Smith Group Asset Management's largest Q3 2015 buy was Citrix Systems Inc: 569,631 shares worth $31.4M.
- Smith Group Asset Management added most to Foot Locker in Q3 2015, an estimated $31.9M increase.
- Smith Group Asset Management's biggest Q3 2015 reduction was United Therapeutics, cutting an estimated $24.4M.
- Smith Group Asset Management fully exited DST Systems Inc. in Q3 2015, selling an estimated $64.8M.
- Smith Group Asset Management's ten largest holdings make up 27% of its $2.63B portfolio in Q3 2015.
- Smith Group Asset Management opened 61 new positions and closed 50 in Q3 2015.
- Smith Group Asset Management's portfolio value fell 11% quarter-over-quarter to $2.63B.
Based on Smith Group Asset Management's 13F filing for Q3 2015, filed 23 Oct 2015.